Cargando…
Direct inhibition of the DNA-binding activity of POU transcription factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication
The development of small molecules to control gene expression could be the spearhead of future-targeted therapeutic approaches in multiple pathologies. Among heterocyclic dications developed with this aim, a phenyl-furan-benzimidazole dication DB293 binds AT-rich sites as a monomer and 5′-ATGA seque...
Autores principales: | Peixoto, Paul, Liu, Yang, Depauw, Sabine, Hildebrand, Marie-Paule, Boykin, David W., Bailly, Christian, Wilson, W. David, David-Cordonnier, Marie-Hélène |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2425483/ https://www.ncbi.nlm.nih.gov/pubmed/18440973 http://dx.doi.org/10.1093/nar/gkn208 |
Ejemplares similares
-
Essential but partially redundant roles for POU4F1/Brn-3a and POU4F2/Brn-3b transcription factors in the developing heart
por: Maskell, Lauren J, et al.
Publicado: (2017) -
Indole and Benzimidazole Bichalcophenes: Synthesis, DNA Binding and Antiparasitic Activity
por: Farahat, Abdelbasset A., et al.
Publicado: (2018) -
Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines
por: Nhili, Raja, et al.
Publicado: (2013) -
Pharmacologic efficacy of PU.1 inhibition by heterocyclic dications: a mechanistic analysis
por: Stephens, Dominique C., et al.
Publicado: (2016) -
Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction
por: Yamanaka, Tomoyuki, et al.
Publicado: (2010)